Please login to the form below

Not currently logged in
Email:
Password:

PureTech

This page shows the latest PureTech news and features for those working in and with pharma, biotech and healthcare.

Boehringer’s head of pharma heads for the exit

Boehringer’s head of pharma heads for the exit

Carine Bruillon. Recent deals have included a 325m acquisition of AMAL Therapeutics to gain access to its cancer vaccine technology, a $226m alliance with UK-listed biotech PureTech Health to develop

Latest news

More from news
Approximately 4 fully matching, plus 6 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    The products have completed phase IIa studies and PureTech has created a subsidiary, resTORbio to develop the two compounds. ... PureTech has put $15m into resTORbio and may allocate a further $10m to the programme.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • PureTech Health appoints new chief financial officer PureTech Health appoints new chief financial officer

    Joep Muijrers joins the biopharma from Life Sciences Partners. Clinical-stage biopharmaceutical company PureTech Health has bolstered the team with a new chief financial officer in the form of Joep Muijrers. ... Daphne Zohar, founder and chief executive

  • John LaMattina joins Frequency Therapeutics in advisory role John LaMattina joins Frequency Therapeutics in advisory role

    Alongside his new role LaMattina will continue to serve as an independent non-executive director at PureTech Health.

  • Former GSK exec joins PureTech Health Former GSK exec joins PureTech Health

    Dr Atul Pande becomes chief medical officer. Boston, US-based PureTech Health has appointed Dr Atul Pande as its new chief medical officer, responsible for the firm's pipeline in immune, ... Dr Pande currently serves on the board of directors for Karuna

  • PureTech Health appoints chief scientific officer PureTech Health appoints chief scientific officer

    Boston, US-based PureTech Health has appointed Dr Joseph Bolen as its chief scientific officer. ... Daphne Zohar, chief executive officer of PureTech Health, said: “We are tremendously excited to bring Joe's visionary leadership and drug development

  • PureTech appoints Joseph Bolen as entrepreneur-in-residence PureTech appoints Joseph Bolen as entrepreneur-in-residence

    And Vincent Hennemand joins as VP, company development and operations. Boston-based PureTech Health has appointed Joseph Bolen (pictured) as entrepreneur-in-residence. ... As PureTech's entrepreneur-in-residence he will work with the firm's company

More from appointments
Approximately 5 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics